Skip to content
value.today

LabStyle Innovations Corp.

🇺🇸 Newark, Delaware, USABiotechnologyFounded 2011
Total raised
$11 M
4 rounds on record
Latest round
$4 M
Sep 2014
First round on record
Sep 2012
Today
Went public
See the company page

LabStyle Innovations Corp. is listed today as DarioHealth Corp.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding, 14 other private sales on record. Open the number of investors for the round's details.

Funding rounds of LabStyle Innovations Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2025$18 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Sep 2025

Investors in this round

10 investors had bought by the notice of Oct 7, 2025: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chen Franco-Yehuda · Executive Officer, Director · Chief Financial Officer, Treasurer, and Secretary
  • Erez Raphael · Executive Officer · Chief Executive Officer
  • Steven Nelson · Executive Officer · Chief Commercial Officer
  • Adam K. Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Lawrence M. Leisure · Director
  • Yoav Shaked · Director · Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chen Franco-Yehuda, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D, newest notice filed Oct 7, 2025. Read the notice at the SEC.

equity, optionsSEC
Jan 2025$7 MPrivate placement after listing$2 to $10 million

LabStyle Innovations Corp.: Private sale, Jan 2025

Investors in this round

18 investors had bought by the notice of Jan 17, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$1,000
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Erez Raphael · Executive Officer, Director · Chief Executive Officer
  • Steven Nelson · Executive Officer · Chief Commercial Officer
  • Zvi Ben David · Executive Officer · Chief Financial Officer, Treasurer, and Secretary
  • Adam K. Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Jon M. Kaplan · Director
  • Yoav Shaked · Director · Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “"Represents a purchase price for 4,950 shares of Series D-2 Preferred Stock and 1,850 shares of Series D-3 Preferred Stock (together, ""Preferred Stock""). The Preferred Stock is convertible into shares of the issuer's common stock, par value $0.0001."”

Signed by Zvi Ben David, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D, newest notice filed Jan 17, 2025. Read the notice at the SEC.

equitySEC
Dec 2024$19 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Dec 2024

Investors in this round

29 investors had bought by the notice of Jan 17, 2025: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
$1,000
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Erez Raphael · Executive Officer, Director · Chief Executive Officer
  • Steven Nelson · Executive Officer · Chief Commercial Officer
  • Zvi Ben David · Executive Officer · Chief Financial Officer, Treasurer, and Secretary
  • Adam K. Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Jon M. Kaplan · Director
  • Yoav Shaked · Director · Chairman of the Board

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “"Represents a purchase price for 7,055 shares of Series D Preferred Stock and 11,750 shares of Series D-1 Preferred Stock (together, the ""Preferred Stock""). The Preferred Stock is convertible into shares of issuer's common stock, par value $0.0001."”

Signed by Zvi Ben David, Chief Financial Officer, Treasurer, and Secretary. Source: SEC Form D, newest notice filed Jan 17, 2025. Read the notice at the SEC.

equitySEC
Feb 2024$22 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Feb 2024

Investors in this round

119 investors had bought by the notice of Feb 29, 2024: 119 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,400,700
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Raphael Erez · Executive Officer, Director · Chief Executive Officer and Director
  • Richard Anderson · Executive Officer · President
  • Yoav Shaked · Executive Officer · Chairman of the Board of Directors
  • Zvi Ben-David · Executive Officer · Chief Financial Officer, Treasuer and Secretary
  • Adam M. Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Jon M. Kaplan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in all US states, and outside the US

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 29, 2024. Read the notice at the SEC.

equitySEC
May 2023$15 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, May 2023

Investors in this round

18 investors had bought by the notice of May 16, 2023: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$410,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Raphael Erez · Executive Officer, Director · Chief Executive Office and Director
  • Richard Anderson · Executive Officer · President
  • Yoav Shaked · Executive Officer · Chairman of the Board of Directors
  • Zvi Ben-David · Executive Officer · Chief Financial Officer, Treasuer and Secretary
  • Adam M. Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matthesis · Director
  • Hila Karah · Director
  • Jon M. Kaplan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed May 16, 2023. Read the notice at the SEC.

equitySEC
Jun 2021$24 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Jun 2021

Investors in this round

74 investors had bought by the notice of Jun 17, 2021: 74 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer
  • Erez Raphael · Executive Officer, Director
  • Richard Anderson · Executive Officer
  • Zvi Ben-David · Executive Officer
  • Adam Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Richard B Stone · Director
  • Yoav Shaked · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Amount Sold includes $2,750,000 of shares of Common Stock held back to secure indemnification obligations and $5,000,000 of shares of Common Stock issuable based on the earn-out provisions of the Issuer's May 15, 2021 Merger Agreement.”

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 17, 2021. Read the notice at the SEC.

equitySEC
Feb 2021$31 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Feb 2021

Investors in this round

30 investors had bought by the notice of Feb 17, 2021: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $31 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer
  • Erez Raphael · Executive Officer, Director
  • Oded Cohen · Executive Officer
  • Richard Anderson · Executive Officer
  • Zvi Ben-David · Executive Officer
  • Adam Stern · Director
  • Adam Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Richard B Stone · Director
  • Yoav Shaked · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 17, 2021. Read the notice at the SEC.

equitySEC
Jul 2020$29 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Jul 2020

Investors in this round

27 investors had bought by the notice of Aug 4, 2020: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $30 M offered; $1 M still to sell
Smallest investment taken
$250,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$910,224
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer · Chief Operating Officer
  • Erez Raphael · Executive Officer, Director · Chief Executive Officer and Director
  • Richard Anderson · Executive Officer · President and General Manager of North America
  • Zvi Ben-David · Executive Officer · Chief Financial Officer, Secretary and Treasurer
  • Adam Stern · Director
  • Allen Kamer · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Richard B. Stone · Director
  • Yadin D. Shemmer · Director
  • Yoav Shaked · Director · Chairman of the Board of Directors

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in all US states, and outside the US

Remarks in the notice

  • On fees: “In addition to the sales commissions listed above in this Item 15, Aegis Capital Corp. is to receive non-accountable expense allowance of $617,721 and warrants to purchase 10% of the aggregate number of securities sold.”

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 4, 2020. Read the notice at the SEC.

equity, optionsSEC
Feb 2020$70 MPrivate placement after listing$50 to $250 million

LabStyle Innovations Corp.: Private sale, Feb 2020

Investors in this round

34 investors had bought by the notice of Feb 3, 2021: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$70 M of $70 M offered
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$4,900,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer
  • Erez Raphael · Executive Officer, Director
  • Richard Anderson · Executive Officer
  • Zvi Ben-David · Executive Officer
  • Adam Stern · Director
  • Adam Stern · Director
  • Dennis M. McGrath · Director
  • Dennis Matheis · Director
  • Hila Karah · Director
  • Richard B Stone · Director
  • Yoav Shaked · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Stifel, Nicolaus & Company, Incorporated (CRD 793) · St. Louis, MissouriSold in all US states, and outside the US
  • SternAegis Ventures (CRD 15007) · New York, New YorkSold in all US states, and outside the US
  • Cowen and Company, LLC (CRD 7616) · New York, New YorkSold in all US states, and outside the US

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 3, 2021. Read the notice at the SEC.

equitySEC
Nov 2019$21 MPrivate placement after listing$10 to $50 million

LabStyle Innovations Corp.: Private sale, Nov 2019

Investors in this round

167 investors had bought by the notice of Dec 23, 2019: 167 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $25 M offered; $4 M still to sell
Smallest investment taken
$1,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,788,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer
  • Erez Raphael · Executive Officer, Director
  • Jarry Olivier · Executive Officer · President and Chief Commercial Officer
  • Zvi Ben-David · Executive Officer
  • Allen Kamer · Director
  • Dennis M. McGrath · Director
  • Glen D. Moller · Director
  • Hila Karah · Director
  • Richard B. Stone · Director
  • Yalon Farhi · Director
  • Yoav Shaked · Director · Chairman of the Board of Directors

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in all US states, and outside the US

Remarks in the notice

  • On fees: “In addition to the sales commissions listed above in this Item 15, Aegis Capital Corp. is to receive warrants to purchase 14.5% of the Company's common stock issuable upon conversion of the preferred stock sold in this offering.”

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 23, 2019. Read the notice at the SEC.

equitySEC
Dec 2018$3 MPrivate placement after listing$2 to $10 million

LabStyle Innovations Corp.: Private sale, Dec 2018

Investors in this round

5 investors had bought by the notice of Dec 20, 2018: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer · Chief Operating Officer
  • Erez Raphael · Executive Officer, Director
  • Jarry Olivier · Executive Officer · President and Chief Commercial Officer
  • Zvi Ben-David · Executive Officer
  • Allen Kamer · Director
  • Dennis M. McGrath · Director
  • Glen M. Moller · Director
  • Hila Karah · Director
  • Richard B. Stone · Director
  • Yalon Farhi · Director
  • Yoav Shaked · Director · Chairman of the Board of Directors

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 20, 2018. Read the notice at the SEC.

equity, optionsSEC
Feb 2018$7 MPrivate placement after listing$2 to $10 million

LabStyle Innovations Corp.: Private sale, Feb 2018

Investors in this round

29 investors had bought by the notice of Mar 14, 2018: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$16,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dror Bacher · Executive Officer · Chief Operating Officer
  • Erez Raphael · Executive Officer, Director · Chairman of the Board of Directors and Chief Executive Officer
  • Zvi Ben-David · Executive Officer · Chief Financial Officer, Treasurer and Secretary
  • Allen Kamer · Director
  • Dennis M. McGrath · Director
  • Hila Karah · Director
  • Malcolm Hoenlein · Director
  • Rami Yehudiha · Director
  • Richard B. Stone · Director
  • Yalon Farhi · Director
  • Yossi Bahagon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 14, 2018. Read the notice at the SEC.

equity, optionsSEC
Jan 2017$5 MPrivate placement after listing$2 to $10 million

LabStyle Innovations Corp.: Private sale, Jan 2017

Investors in this round

20 investors had bought by the notice of Jan 23, 2017: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Erez Raphael · Executive Officer
  • Zvi Ben-David · Executive Officer · Chief Financial Officer
  • Dennis McGrath · Director
  • Hila Karah · Director
  • Malcolm Hoenlein · Director
  • Rami Yehudiha · Director
  • Richard Stone · Director
  • Yalon Farhi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$1,981,021 of the securities sold in the offering are being held in escrow pending the company obtaining stockholder approval.”

Signed by Zvi Ben-David, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 23, 2017. Read the notice at the SEC.

equity, optionsSEC
Feb 2015$2 MPrivate placement after listingUnder $2 million

LabStyle Innovations Corp.: Private sale, Feb 2015

Investors in this round

20 investors had bought by the notice of Mar 9, 2015: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
$9,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$264,900
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Erez Raphael · Executive Officer, Director
  • Zvi Ben David · Executive Officer, Director
  • Dennis McGrath · Director
  • Hila Karah · Director
  • Malcolm Hoenlein · Director
  • Peter Kash · Director
  • Rami Yehudiha · Director
  • Richard Stone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Newport Coast Securities, Inc. (CRD 16944) · New York, New YorkSold in all US states

Remarks in the notice

  • On the use of proceeds: “Use of proceeds will be for general corporate purposes which may include compensation for executives.”

Signed by Zvi Ben David, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 9, 2015. Read the notice at the SEC.

equity, optionsSEC
Sep 2014$4 MNo. 4$2 to $10 million

LabStyle Innovations Corp.: Raise no. 4, Sep 2014

Investors in this round

15 investors had bought by the notice of Oct 3, 2014: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Erez Raphael · Executive Officer, Director
  • Gadi Levin · Executive Officer
  • Dennis McGrath · Director
  • Malcolm Hoenlein · Director
  • Oren Fuerst, PhD · Director
  • Rami Yehudiha · Director
  • Richard Stone · Director
  • Steven Kaplan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On fees: “Issuer paid a financial advisor cash advisory fees in conjunction with the consummation of this offering.”
  • On the use of proceeds: “Proceeds to be used for working capital. Working capital may be used to pay salaries.”

Signed by Gadi Levin, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 3, 2014. Read the notice at the SEC.

equity, optionsSEC
Feb 2014$4 MNo. 3$2 to $10 million

LabStyle Innovations Corp.: Raise no. 3, Feb 2014

Investors in this round

19 investors had bought by the notice of Mar 5, 2014: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$14,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$293,068
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Erez Raphael · Executive Officer, Director
  • Gadi Levin · Executive Officer, Director
  • Adam Stern · Director
  • David Weintraub, MD · Director
  • Dennis McGrath · Director
  • Malcolm Hoenlein · Director
  • Oren Fuerst, PhD · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Roth Capital Partners LLC (CRD 15407) · New York, New YorkSold in all US states

Signed by Gadi Levin, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 5, 2014. Read the notice at the SEC.

equity, optionsSEC
Apr 2013$2 MNo. 2Under $2 million

LabStyle Innovations Corp.: Raise no. 2, Apr 2013

Investors in this round

5 investors had bought by the notice of Apr 12, 2013: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $10 M offered; $8 M still to sell
Smallest investment taken
$10,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$800,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mordechi Hershkowitz · Executive Officer
  • Oren Fuerst, Ph.D. · Executive Officer, Director
  • Shilo Ben Zeev · Executive Officer, Director
  • Adam D. Stern · Director
  • David Weintraub, MD · Director
  • Malcolm Hoenlein · Director
  • Nahum D. Melumad · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in all US states

Signed by Oren Fuerst, Ph.D., Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 12, 2013. Read the notice at the SEC.

equity, optionsSEC
Sep 2012$1 MNo. 1Under $2 million

LabStyle Innovations Corp.: Raise no. 1, Sep 2012

Investors in this round

19 investors had bought by the notice of Oct 11, 2012: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
$275,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mordechi Hershkowitz · Executive Officer
  • Oren Fuerst, Ph.D. · Executive Officer, Director
  • Shilo Ben Zeev · Executive Officer, Director
  • Adam Stern · Director
  • David Weintraub · Director
  • Malcolm Hoenlein · Director
  • Nahum Melumad · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in all US states
  • Charles Vista LLC (CRD 132650) · New York, New YorkSold in all US states
  • Spencer Trask Ventures, Inc. (CRD 28373) · New York, New YorkSold in all US states
  • Mediterranean Securities Group, LLC (CRD 153755) · Boca Raton, FloridaSold in AL, AR, CA, CO, CT, FL, GA, IA, IL, IN, LA, MD, MI, MO, MS, NC, NE, NJ, NV, NY, OH, PA, TX, VA, WA, WI

Remarks in the notice

  • On fees: “All finders are broker-dealers registered with the SEC and FINRA.”

Signed by Oren Fuerst, Ph.D., Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 11, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company DarioHealth Corp., its revenue in fiscal 2025 came from these product and service lines: Hardware and Consumable Products $7.43 million (33%).

    Annual report (SEC XBRL) · Dec 2025

  • LabStyle Innovations Corp. chose not to state its revenue in its newest notice of a funding round (Oct 2025).

    SEC Form D · Oct 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2025

Products and services#

No products or services of LabStyle Innovations Corp. are on record.

Investors#

No investor of LabStyle Innovations Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 19 investors.

Largest shareholders today

Institutions holding DarioHealth Corp. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by LabStyle Innovations Corp.
NameRoleNamed in
Chen Franco-YehudaChief Financial Officer, Treasurer, and SecretaryOct 2025
Erez RaphaelChief Executive OfficerOct 2025
Steven NelsonChief Commercial OfficerOct 2025
Zvi Ben DavidChief Financial Officer, Treasurer, and SecretaryJan 2025
Raphael ErezChief Executive Officer and DirectorFeb 2024
Richard AndersonPresidentFeb 2024
Yoav ShakedChairman of the Board of DirectorsFeb 2024
Zvi Ben-DavidChief Financial Officer, Treasuer and SecretaryFeb 2024
Dror BacherExecutive officerJun 2021
Oded CohenExecutive officerFeb 2021
Jarry OlivierPresident and Chief Commercial OfficerDec 2019
Gadi LevinExecutive officerOct 2014
Mordechi HershkowitzExecutive officerApr 2013
Oren Fuerst, Ph.D.Executive officerApr 2013
Shilo Ben ZeevExecutive officerApr 2013
Adam K. SternDirectorOct 2025
Chen Franco-YehudaChief Financial Officer, Treasurer, and SecretaryOct 2025
Dennis M. McGrathDirectorOct 2025
Dennis MatheisDirectorOct 2025
Hila KarahDirectorOct 2025
Lawrence M. LeisureDirectorOct 2025
Yoav ShakedChairman of the BoardOct 2025
Erez RaphaelChief Executive OfficerJan 2025
Jon M. KaplanDirectorJan 2025
Adam M. SternDirectorFeb 2024
Raphael ErezChief Executive Officer and DirectorFeb 2024
Dennis MatthesisDirectorMay 2023
Adam SternDirectorJun 2021
Richard B StoneDirectorJun 2021
Allen KamerDirectorAug 2020
Richard B. StoneDirectorAug 2020
Yadin D. ShemmerDirectorAug 2020
Glen D. MollerDirectorDec 2019
Yalon FarhiDirectorDec 2019
Glen M. MollerDirectorDec 2018
Malcolm HoenleinDirectorMar 2018
Rami YehudihaDirectorMar 2018
Yossi BahagonDirectorMar 2018
Dennis McGrathDirectorJan 2017
Richard StoneDirectorJan 2017

Went public since 2014. Its SEC number is that of a company listed on a stock exchange.